NASDAQ BBIO opened at $36.74 on Monday. BridgeBio Pharma has a 52 week low of $21.62 and a 52 week high of $39.47. The company has a 50 day moving average price of $34.17 and a 200 day moving ...

The Arena Media Brands, LLC and respective content providers may receive compensation for some links to products and services on this website. Looking for a new pair of highly rated women's ...

Marksans Pharma Ltd shares recorded gains on Tuesday, following a significant regulatory approval obtained by its UK-based subsidiary, Relonchem Ltd. Relonchem Ltd has secured Marketing ...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.06% to 42,556.82 while the NASDAQ climbed 0.29% to 18,241.49.

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company ...

The shares of a Microcap Pharmaceutical company that focuses on manufacturing ayurvedic and herbal products with a well-built presence in Human Pharma and the Veterinary space are in focus after ...

Logically, if the US wants to keep costs low, there cannot be any tariff wars in the pharma sector. But logic does not work in President Trump’s New World Order, where offers can be made to buy ...

Nippon India Small Cap Fund (G) 416.27 16,74,471 0.82 Nippon India Small Cap Fund (IDCW) 416.27 16,74,471 0.82 Nippon India Small Cap Fund (B) 416.27 16,74,471 0.82 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April 1982. Pursuant to the Scheme of Amalgamation name of the Company was changed from Tasc Pharmaceuticals ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.